Queen’s University alumnus Adolfo de Bold is one of six nominees to The Canadian Medical Hall of Fame. The announcement was made today at the university’s New Medical Building, the first time the event has been held in Kingston.

Also called the Father of the Field of Cardiovascular Endocrinology, Dr. de Bold’s work led to the discovery of atrial natriurectic peptide (ANP), a hormone secreted by the heart muscle cells. He discovered the heart uses ANP to modulate blood pressure, blood volume and cardiovascular growth. This opened up a new field of research which has led to new heart failure therapies.

“We are honoured and very excited to be hosting the 2014 Canadian Medical Hall of Fame Induction,” says Richard Reznick, dean of Queen's Faculty of Health Sciences. “The inductees announced today are true medical heroes in every sense.  We are particularly proud that one of inductees, Dr. de Bold, is an alumnus and former faculty member.”

Dr. de Bold started working at Queen’s in 1974 and rose to full professorship by 1985. Along with this new honour, Dr. de Bold has earned a number of other honours including the Royal Society of Canada McLaughlin Medal in Medical Research, the International Society for Hypertension Research Award and the CIBA Award from the American Heart Association.

The Canadian Medical Hall of Fame (CMHF) is the only national museum in the world dedicated to celebrating medical heroes. Each year up to six laureates are selected by a committee of prominent medical professionals and scientists from across Canada to receive this esteemed award.

CMHF is committed to educating Canadians about our homegrown heroes and fostering the development of the next generation of scientists, physicians and builders through nationwide educational programs.

The induction ceremony will take place at the Roger’s K-Rock Centre in Kingston on April 24, 2014.